2-((4-Methyl-4H-1,2,4-triazol-3-yl)thio)-N-(4-styrylphenyl)acetamide

Catalog No. :
ACXASA915
CAS No. :
348141-95-7
Molecular Formula :
C19H18N4OS
Molecular Weight :
350.45

IUPAC Name:(E)-2-((4-methyl-4H-1,2,4-triazol-3-yl)thio)-N-(4-styrylphenyl)acetamide

2-((4-Methyl-4H-1,2,4-triazol-3-yl)thio)-N-(4-styrylphenyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((4-Methyl-4H-1,2,4-triazol-3-yl)thio)-N-(4-styrylphenyl)acetamide
IUPAC Name(E)-2-((4-methyl-4H-1,2,4-triazol-3-yl)thio)-N-(4-styrylphenyl)acetamide
MDL No.MFCD01443421
Molecular FormulaC19H18N4OS
Molecular Weight350.45
SMILESO=C(NC1=CC=C(/C=C/C2=CC=CC=C2)C=C1)CSC3=NN=CN3C
InChI KeyQLNFSIVFURVOSV-BQYQJAHWSA-N
Synonym2-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]-N-[4-(2-phenylvinyl)phenyl]acetamide;2-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]-N-{4-[(E)-2-phenylethenyl]phenyl}acetamide;Acetamide, 2-[(4-methyl-4H-1,2,4-triazol-3-yl)thio]-N-[4-(2-phenylethenyl)phenyl]-
CAS No.348141-95-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACXASA915 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXASA915 route product structure diagram
    ACXASA915348141-95-7
Inquiry

2. ACXASA915 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMTRG752 route compound structure diagram
    ACMTRG75224854-43-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXASA915 route product structure diagram
    ACXASA915348141-95-7
Inquiry

Comments (0)